Retinal Vein Occlusion

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Retinal Vein Occlusion
  • Phoenix, Arizona
  • +140 more
Jul 20, 2022

Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))

Completed
  • Retinal Vein Occlusion
  • Macula Edema
  • TLC399 (ProDex)
  • Phoenix, Arizona
  • +19 more
Nov 24, 2021

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal CLS-TA
  • +2 more
  • Phoenix, Arizona
  • +91 more
Apr 22, 2021

Retinal Vein Occlusion, Diabetic Macular Edema Trial in Beverly Hills, Boston (KPI-121 0.25% Ophthalmic Suspension, KPI-121 1.0%

Completed
  • Retinal Vein Occlusion
  • Diabetic Macular Edema
  • KPI-121 0.25% Ophthalmic Suspension
  • KPI-121 1.0% Ophthalmic Suspension
  • Beverly Hills, California
  • +1 more
Dec 9, 2020

Macular Edema, Retinal Vein Occlusion Trial in Lexington, Boston, Cleveland (Fluocinolone Acetonide)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • Fluocinolone Acetonide
  • Lexington, Kentucky
  • +2 more
May 8, 2015

Retinal Vein Occlusion Trial in United States (ranibizumab, Peripheral Laser)

Completed
  • Retinal Vein Occlusion
  • Beverly Hills, California
  • +5 more
Nov 27, 2013

Retinal Vein Occlusion Trial in United States (pegaptanib sodium)

Completed
  • Retinal Vein Occlusion
  • pegaptanib sodium
  • Tucson, Arizona
  • +34 more
Jan 17, 2007